How does liver disease affect tigecycline dosage?

How does liver disease change the usual tigecycline dose?

Liver disease reduces the way the body clears tigecycline in many patients. In mild cases, doctors still use the standard loading dose of 100 mg followed by 50 mg every 12 hours. In severe liver disease, however, they reduce the maintenance dose to 25 mg every 12 hours while keeping the 100 mg loading dose intact.

Why keep the loading dose when liver impairment is strong?

The loading dose quickly brings drug levels up to the needed range even when the body cannot clear it later. Once the first 100 mg is gegeben, the halved maintenance dose prevents later accumulation that would occurs if the normal 50 mg schedule were kept.

What happens if the dose is not adjusted in severe cases?

Without adjustment, tigecycline builds up because the liver cannot remove it properly. This raises the chance of side effects such as nausea, vomiting, and increased liver enzymes. Some patients also report more pronounced gastrointestinal upset.

Can doctors measure drug levels to guide adjustment?

No routine blood test measures tigecycline concentration for clinical use. Adjustment relies on clinical judgment based on the Child-Pugh score rather than measured levels. Doctors therefore look at liver-function numbers and patient response to decide whether further dose tweaks are needed.

How long does the adjusted dose stay on?

The adjusted 25 mg every 12 hours schedule continues throughout treatment. Treatment length depends on the infection being treated rather than on the dose itself. Most courses last 5 to 14 days once the infection reaches the desired level of control.

Why are companies challenging this patent?

Tigecycline formulations fall under several patents held by Wyeth and later Pfizer. Challengers argue that earlier patents on tetracyclines cover similar modified structures. Some disputes focus on the 9-t-butylglycylamido substitution that defines tigecycline, which has led to generic launches in some markets after patent expiry.

When does the main patent expire?

The primary composition-of-matter patent for tigecycline expires in the United States around 2024. [1]